DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,418 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,383,818 | -0.3% | 9,541 | -0.3% | 0.74% | -0.7% |
Q1 2024 | $2,390,070 | +5.3% | 9,571 | -2.4% | 0.74% | -2.5% |
Q4 2023 | $2,269,676 | -7.2% | 9,811 | -0.5% | 0.76% | -18.6% |
Q3 2023 | $2,446,514 | +2.7% | 9,861 | -0.6% | 0.94% | +2.4% |
Q2 2023 | $2,381,040 | -5.5% | 9,921 | -0.8% | 0.92% | -21.9% |
Q1 2023 | $2,519,392 | -10.1% | 9,996 | -5.3% | 1.17% | -16.1% |
Q4 2022 | $2,803,101 | +2.8% | 10,561 | +0.1% | 1.40% | -18.5% |
Q3 2022 | $2,726,000 | -3.3% | 10,554 | -5.1% | 1.72% | +4.1% |
Q2 2022 | $2,819,000 | -17.5% | 11,117 | -4.6% | 1.65% | -6.6% |
Q1 2022 | $3,418,000 | -14.7% | 11,651 | -4.4% | 1.77% | -12.8% |
Q4 2021 | $4,008,000 | +6.8% | 12,181 | -1.2% | 2.03% | -4.7% |
Q3 2021 | $3,752,000 | +14.0% | 12,326 | +0.5% | 2.12% | +8.5% |
Q2 2021 | $3,291,000 | +10.7% | 12,264 | -7.2% | 1.96% | +1.3% |
Q1 2021 | $2,974,000 | +0.6% | 13,214 | -0.8% | 1.93% | -7.0% |
Q4 2020 | $2,957,000 | -0.0% | 13,314 | -3.1% | 2.08% | -8.4% |
Q3 2020 | $2,958,000 | +17.1% | 13,738 | -3.8% | 2.27% | +9.7% |
Q2 2020 | $2,526,000 | +26.4% | 14,288 | -1.0% | 2.07% | +6.7% |
Q1 2020 | $1,998,000 | -11.2% | 14,438 | -1.5% | 1.94% | +6.7% |
Q4 2019 | $2,250,000 | +1.5% | 14,663 | -4.5% | 1.82% | -8.9% |
Q3 2019 | $2,216,000 | -2.1% | 15,347 | -3.2% | 1.99% | -5.9% |
Q2 2019 | $2,264,000 | +6.1% | 15,847 | -1.9% | 2.12% | +4.2% |
Q1 2019 | $2,133,000 | +28.0% | 16,156 | 0.0% | 2.03% | +13.6% |
Q4 2018 | $1,666,000 | – | 16,156 | – | 1.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |